HANXBIO-B(03378.HK) Included in FTSE Global Micro Cap Index
NewTimeSpace News: Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378.HK) announced that pursuant to FTSE Russell’s quarterly index review, the Company has been admitted to the FTSE Global Micro Cap Index under the FTSE Global Equity Index Series, with the inclusion effective after market close on 19 June 2026. The Board believes this inclusion broadly recognises the Company’s solid fundamentals, innovation capacity and growth potential from international capital markets, expected to lift its visibility among global institutional investors and analysts, attract inflows from passive and active funds tracking relevant indices, diversify shareholder base and enhance trading liquidity of its shares.
NewTimeSpace News: On 22 June 2026, Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378.HK) issued a voluntary announcement. Following the quarterly index review conducted by FTSE Russell for the FTSE Global Equity Index Series, the Company has been selected as a constituent stock of the FTSE Global Micro Cap Index, and the inclusion took effect after market close on 19 June 2026.
The FTSE Global Equity Index Series spans 49 developed and emerging markets worldwide, covering more than 19,000 large-cap, mid-cap, small-cap and micro-cap stocks globally.
The Board of Directors opines that the inclusion serves as wide recognition from international capital markets of the Group’s sound fundamentals, innovative capabilities and long-term growth prospects. It is anticipated to boost the Company’s profile among global institutional investors and industry analysts, draw capital inflows from both passively-managed and actively-managed funds tracking the relevant index benchmarks, further diversify the Group’s shareholder structure and improve the market liquidity of its listed shares.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
